| Project/Area Number |
22790780
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
NEGISHI Kosuke 東京大学, 医学部附属病院, 特任臨床医 (40572219)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 急性腎障害 / 薬剤性腎障害 / バイオマーカー / 脂肪酸結合蛋白 / ヨード造影剤 / 過酸化脂質 |
|---|
| Research Abstract |
I evaluated the utility of urine L-FABP for Acute kidney injury(AKI) biomarker in animal drug-induced renal injury models induced by radio-contrast(RC), gentamicin and vancomycin. In RC-induced AKI model, L-FABP was shed into the urine in a dose-dependent manner, and was demonstrated that hypoperfusion of peri-tubular capillary was one of the key factors to induce its renal expression and the elevation of its urinary shedding. Furthermore, it was confirmed that L-FABP was a useful biomarker that responded to RC sensitively. However, additional biomarker studies are needed for gentamicin and vancomycin-induced AKI. In future, it is expected that further biomarker studies would improve diagnostic accuracy of drug-induced renal injury.
|
